BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3770069)

  • 1. Pharmacokinetics of cimetidine after subchronic administration.
    Chin TW; Spino M; MacLeod SM; Mahon WA; Soldin SJ
    Eur J Clin Pharmacol; 1986; 30(6):741-4. PubMed ID: 3770069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
    Lima DR; Santos RM; Werneck E; Andrade GN
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine pharmacokinetics and dosage requirements in children.
    Somogyi A; Becker M; Gugler R
    Eur J Pediatr; 1985 May; 144(1):72-6. PubMed ID: 4018106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of repeat dosing with cimetidine on the pharmacokinetics of intravenous granisetron in healthy volunteers.
    Youlten L
    J Pharm Pharmacol; 2004 Feb; 56(2):169-75. PubMed ID: 15005875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cimetidine after single doses and during continuous treatment.
    Bodemar G; Norlander B; Walan A
    Clin Pharmacokinet; 1981; 6(4):306-15. PubMed ID: 7249489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of cimetidine in Zollinger-Ellison syndrome.
    Ziemniak JA; Madura M; Adamonis AJ; Olinger EJ; Dreyer M; Schentag JJ
    Dig Dis Sci; 1983 Nov; 28(11):976-80. PubMed ID: 6628158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine kinetics and dynamics in patients with severe liver disease.
    Villeneuve JP; Fortunet-Fouin H; Arsène D
    Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.
    Ziemniak JA; Assael BM; Padoan R; Schentag JJ
    Eur J Clin Pharmacol; 1984; 26(2):183-9. PubMed ID: 6723756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene.
    Muirhead MR; Somogyi AA; Rolan PE; Bochner F
    Clin Pharmacol Ther; 1986 Oct; 40(4):400-7. PubMed ID: 3757403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine disposition in obesity.
    Abernethy DR; Greenblatt DJ; Matlis R; Gugler R
    Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cimetidine dose timing on oral propranolol kinetics in adults.
    Asgharnejad M; Powell JR; Donn KH; Danis M
    J Clin Pharmacol; 1988 Apr; 28(4):339-43. PubMed ID: 3392231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and metabolism of cimetidine in neonates.
    Ziemniak JA; Wynn RJ; Aranda JV; Zarowitz BJ; Schentag JJ
    Dev Pharmacol Ther; 1984; 7(1):30-8. PubMed ID: 6697868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.